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Abstract: 
Background: Although the United States is one of the countries at the leading edge of medical breakthroughs and treatments, there are 
great disparities in the access to care among different socioeconomic strata. One of the most striking discrepancies regarding access to 
care is found among the ranks of the Hispanic population, which is the fastest growing minority in the United States, but for which 
  cancer is the third leading cause of death. It is clear that better and timely treatment for cancer patients belonging to this minority is 
needed. Patient navigators can be an important tool to improve access to care of patients belonging to this minority group.
Methods: Through a systemic search, we identified seven articles that employed patient navigators for Hispanic cancer patients. The 
identified studies addressed very limited pathology, three studying breast and four colon cancer patients.
Conclusions: The presence of patient navigation can be an effective to remove impediments that limit the access to care in minority 
populations and can improve outcomes in Hispanic patients suffering from cancer. Further research to evaluate the cost of patient navi-
gation in relationship to the added benefit early diagnosis, continued follow up and treatment is needed.
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Introduction
Cancer  is  one  of  leading  causes  of  death  in  the 
United States. Despite advances in medical knowl-
edge and technologies, diagnosing cancer in a timely 
manner  and  continued  follow  up  and  treatment  in 
cancer patients is still a challenge. In addition, dis-
parities exist when treating Hispanic and non-Hipanic 
patients.1–4 In the Hispanic population, many barriers 
limiting access to care were identified. These consist 
of  education,  cultural  background  and  financial 
means.5 It was also noted that cancer is a leading 
cause of death in the Hispanic population, with His-
panic  men  and  women  having  the  lowest  survival 
rates for most cancers.5 In addition, cancer in this 
patient population is generally found at later stages5 
when there is more difficult to treat and the likelihood 
for cure is significantly decreased.
Brain and nervous system cancers are a leading 
cause  of  cancer  related  deaths  among  Hispanics. 
However, there is a lack of specific interventions 
targeting this “at risk population”.5 It has been shown 
that Hispanic children suffering from brain cancers 
have  reduced  access  to  high-quality,  high-volume 
neurological  oncology  surgical  centers6—they  are 
32% less likely to be seen when compared to their 
white  counterparts  (odds  ratio  0.68).  In  addition, 
research found that mortality rates and adverse dis-
charge disposition rates were lower when proce-
dures were performed at high-volume hospitals and 
by  high-volume-  neurosurgeons.7  Thus,  improving 
the  access  to  specialized  medical  care  for  the 
  Hispanic  population  may  influence  positively  the 
patient outcomes.
The access to medical care is often impeded by 
various barriers, which can be different across differ-
ent ethnic groups. Barriers can be financial, or non 
financial, such as logistical barriers for access to care, 
negative healthcare experiences at previous encoun-
ters, or language barriers resulting in poor patient-
provider  communication.4,8–14  Nonetheless,  these 
barriers deter the timely care for cancer patients, with 
significant negative impact on patient survival.
Patient  navigator  programs  have  recently  been 
used in different community and Academic Cancer 
Centers to improve the access to care for Hispanic 
and  other  minority  patients.  Patient  navigators  are 
trained health care professionals who provide patients 
with  information  and  research  on  the  illness  the 
patient  is  afflicted  with.  They  also  advocate  on 
patient’s  behalf,  and  help  patients  benefit  from  an 
integrative care approach to their illness.   Unfortunately, 
no systematic reviews have been done to determine if 
this is an effective intervention, and if the presence of 
patient navigators, which imposes additional costs on 
an already strained system, can effectively improve 
the screening and early diagnosis and treatment of 
Hispanic and other minority patients.
Materials and Methods
A comprehensive literature review on patient naviga-
tion programs was conducted. The key words used in 
the Medline database were cancer and/or oncology 
and patient navigator. Fifty three publications des-
cribing patient navigator programs were identified. 
These trials look at the use of patient navigation in 
treating patients with various cancers and how patient 
navigation can improve follow-up, treatment and out-
come in patients with cancers. Seven articles included 
specific data on Hispanic patient’s access to cancer 
care.1,2,15–19
Results
From  the  seven  studies  identified,  which  included 
measures  focused  on  improving  Hispanic  patient’s 
access to cancer care, four concentrated on colorectal 
cancer (colonoscopy) screening,1,16,18,19 while three on 
the access to oncological care for women with abnor-
mal mammograms.2,15,17 All six studies were published 
since 2005, underlying the relative newest of research 
in this topic.
The importance of patient navigator (Pn) 
in increasing colorectal cancer (CRC) 
screening
Four studies recruited patients eligible for colorectal 
cancer screening (Table 1). Only one study focused 
on conceptually determining the barriers to screening 
colonoscopy in low-income Latino patients,18 while 
the other three studied the use of a patient navigator 
to increase the screening (two randomized studies,16,19 
and one open-access referral system1 Table 1).
In low-income patients (both Latino and White), 
a wide range of barriers to screening colonoscopy 
were identified, such as system barriers (scheduling, 
  financial,  transportation  and  language  difficulties), 
fear (of pain, complications, cancer diagnosis), lack Patient navigators for Hispanic patients
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of desire/motivation, dissuasion by others, and lack 
of provider recommendation.18 There was no clear 
barrier difference found between the Latino and white 
non-Latino patients, except for the language barriers 
and  the  fact  that  Latino  man  seemed  to  talk  less 
about these issues overall then other groups. It is, 
however, worth noticing that is this study, the Latino 
patients  were  less  likely  to  be  insured—31.8%  of 
Latino  patients  had  no  insurance  and  only  16.6% 
of white patients had no insurance; while 36.4% of 
Latino  patients  received  colonoscopy  compared  to 
44.4% of white patients.
Two of the three studies of patient navigator use 
in  improving  the  rate  of  screening  colonoscopy 
employed a prospective randomized design. The first 
study intended to determine if the Patient Navigator 
can increases the rate of CRC screening in the low- 
income,  primary  care  practice  in  East  Harlem, 
New York City. The subjects included in this study 
included men and women aged 50 or older who had 
not had a fecal occult blood test (FOBT) within the 
previous year, had not had a flexible sigmoidoscopy 
(FS) or barium enema within the past 3–5 years, and 
had not had a colonoscopy within the past 10 years. 
The 78 asymptomatic participants were randomized in 
two groups: 38 patients received Patient   Navigator 
services and 40 did not. The two groups did not differ 
in any characteristics. Majority of the patients (82.1%) 
of  the  patients  were  Hispanic,  and  74.4%  were 
females.  The  Patient  Navigator  called  the  patients 
randomized to navigation 2–3 weeks after the initial 
enrollment and addressed any barriers to completion 
of FOBT cards, and the scheduling on FS. If the FS 
was  not  scheduled,  the  Patient  Navigator  assisted 
with the scheduling of FS, and reminded the patients 
of their appointments. At the three-month review, the 
patients randomized in the Patient Navigator inter-
vention  group  had  higher  FOBT  completion  rates 
(42.1% vs. 25%, P = 0.086), and more patients have 
made their endoscopy appointment (18.4% vs. none, 
P = 0.005). At the final review (six months point) 
23.7% of the patients receiving the Patient Navigator 
services completed an endoscopic examination, com-
pared with only 5% of the control group.
A second study from the Mount Sinai School of 
Medicine  analyzed  the  effect  of  Patient  Navigator 
intervention  in  increasing  specifically  the  rate  of 
screening colonoscopy beyond the physician recom-
mendation alone.16 The eligible patients included men 
and women older then 50, asymptomatic for gastroin-
testinal symptoms, and who had received a referral 
for screening colonoscopy. This study enrolled a small 
number of patients (n = 21), out of which 13 were 
randomized  to  the  Patient  Navigator  intervention, 
while 8 were randomized to the control group. The 
Patient Navigator provided the patient with follow-up 
for scheduling, education, and organized and coordi-
nated the transportation services, as well as resched-
uled the colonoscopy appointment if the patient could 
not keep the initial date. Majority of the patients in 
this study were Hispanic (71%), did not have high-
school education (71%), made less then 20,000 a year 
Table 1. Outcome of published patient navigator efficacy studies to improve colon cancer screening for hispanic patient.
citation Design participants Location Hispanic 
patients
Outcome 
measures
Results
Jandorf19 Prospective, 
randomized
78 patients  Primary care 
practice,  
east Harlem,  
new York
82% Increasing  
adherence to  
colon cancer  
screening
Increase in the number 
of patients receiving 
timely endoscopic 
evaluations
Green18 Qualitative, 
descriptive 
40 patients Adult Medicine  
Department,  
Community-based  
(MGH Chelsea)
55% Identify potential  
barriers to  
screening  
colonoscopy
Increased understanding 
of barriers to screening 
colonoscopy in low-
income Hispanics
Christie16 Prospective, 
randomized
21 patients Local Community  
Health Center  
Settlement Health,  
new York
71% Completing  
Screening  
Colonoscopy
Improved compliance 
with screening 
colonoscopy
Chen1 Prospective, 
cohort
532 patients Teaching Hospital,  
new York
55% Completing  
Screening  
Colonoscopy
Improved compliance 
with screening 
colonoscopyRobie et al
4  Clinical Medicine Insights: Oncology 2011:5
(81%) and were uninsured (52%). The results showed 
that more of the navigated patients complete their 
screening colonoscopy (53.28% vs. 13%, P = 0.085) 
then the control patients. Also, less patients refused 
screening  colonoscopy  and  more  patients  were 
rescheduled if the initial appointment was missed in 
the Patient Navigator group.
Finally, a one-arm cohort study is also available 
about  the  use  of  Patient  Navigator  in  order  to 
increase the rate of colonoscopy completion for urban 
minorities.1 The patients were directly referred from 
primary care clinics to a teaching hospital in New York. 
The  patients  were  mostly  African  Americans  and 
  Hispanics. A number of 532 patients were offered 
navigation, out of which 66% completed the   screening 
colonoscopy. The Hispanic patients were 1.67 more 
times likely to complete colonoscopy than African 
Americans  (P  =  0.013).  Hispanic  women  were 
1.5 times more likely to complete colonoscopy then 
Hispanic men (P = 0.009). Important to notice, 16% 
of the patients were diagnosed with significant clini-
cal pathology (such as adenomas).
The importance of patient navigator (Pn) 
in improving follow-up in Hispanic women 
with abnormal breast cancer screening
Three studies focused on the use of Patient Navi-
gator  to  improve  access  to  care  for  patients  with 
abnormal  mammograms  also  included  Hispanic 
patients (Table 2). The first trial was conducted at a 
hospital-based   diagnosis breast health practice at a 
major academic medical   center, and was designed as 
a pre-post intervention study.15 All the patients with 
scheduled visits were included, and the end-point was 
defined as timely   follow-up (less then 120 days from 
the date of the original appointment to the date if the 
diagnostic  evaluation. The  Patient  Navigator  inter-
vention was offered to all patients, and focused on 
patient identification, identification of the barriers to 
care, implementation of a care plan and tracking to 
  completion. During the Patient Navigator   intervention, 
78% of the patients had timely follow-up versus 64% 
preintervention (P , 0.0001). A small percentage of 
the patients were defined as   Hispanic (14%), and no 
significant differences were detected between the dif-
ferent racial groups.
The largest study to date focused on the access to 
care  of  Hispanic  women  with  abnormal  mammo-
grams was conducted in Los Angeles -University of 
  Southern California between 2001–2002 and included 
204 women (85% of which were Latino, and 90% 
foreign  born).2  The  patients  were  randomized  to 
Patient    Navigator  intervention  or  usual  care.  The 
Patient    Navigator  intervention  was  extensive,  and 
contained  structured  phone-based  adherence 
risk assessments, health education and psychological 
counseling,    system  navigation  assistance,  patient 
tracking and reminders, and referral to community 
resources. The intervention group was much more 
likely to achieve diagnosis   resolution then the con-
trol  group  (90%  vs.  66%,  P  ,  0.001),  and  more 
Table 2. Outcome of published patient navigator studies for Hispanic women with abnormal breast cancer screening.
citation Design participants Location Hispanic 
patients
Outcome measures Results
Battaglia,  
2006
Prospective, 
cohort
314 patients Major Academic 
Center, Boston
14% Follow-up after  
abnormal breast  
findings
Increase in the number 
of patients receiving 
timely follow-up
ell, 2006 Prospective, 
randomized
204 patients Public Medical 
Center, Los 
Angeles
84% Follow-up after  
abnormal  
mammogram
Increase in the rate of 
adherence to follow-up 
through diagnostic 
resolution
Ferrante,  
2007
Prospective, 
randomized
105 patients Urban  
University  
Hospital,  
newark
30% Time to diagnosis  
after abnormal  
mammogram,  
decreasing anxiety  
and increasing  
satisfaction
Shorter time to 
diagnosis resolution, 
decreased anxiety, 
improved patient 
satisfactionPatient navigators for Hispanic patients
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timely adherence (77% vs. 57%, P = 0.001) then the 
  control group.
The third study tested the effectiveness of a patient 
navigator  in  improving  the  timelines  to  diagnosis, 
decreasing anxiety, and increasing support in urban 
minority women. The patients were randomized to 
receive  either  standard  care  (n  =  50),  or  standard 
acre plus Patient Navigator intervention (n = 55). The 
Patient  Navigator  provided  the  patients  with  emo-
tional  and  social  support,  helped  patients  make 
appointments,  facilitated  applications  for  financial 
assistance, and facilitated interactions and communi-
cation  with  the  health  care  team.  The  woman  in 
the intervention group had shorter time to diagnosis 
(25 vs. 42.7 days, P = 0.001), lower anxiety scores 
(P  ,  0.001)  and  higher  mean  satisfaction  scores. 
No racial differences were seen in this study, but major-
ity of the patients were black (59%), the number of 
Hispanic patients was relatively low (27.6%), and the 
study did not include non-English speaking patients.
Discussion
Patient navigation is a simple way to help patients 
increase  their  access  to  care,  and  thus  hopefully 
reduce the disparities which exist among medically 
underserved communities across the United States. 
It was first introduced in the 1990s by Dr. Harold 
  Freeman, breast cancer surgeon at Harlem Hospital in 
New York. He noticed that African American women 
with breast cancer were frequently diagnosed at later 
stages than Caucasian women. After reviewing the 
barriers  these  women  faced  during  the  process  of 
receiving medical care, he helped his patients obtain a 
navigator to overcome the obstacles.12,13 Dr. Freeman’s 
program revealed that, in various types of cancer, out-
comes can be improved using patient navigation to 
help the patient obtain the needed medical care.12,13 
Following this program, the notion that Patient Navi-
gators can assist the medically underserved in acquir-
ing proper follow-up and treatment gained remarkable 
support throughout the United States.
Patient Navigation was successfully used in several 
instances to help Hispanic cancer patients to obtain 
medical  treatment.4,8–14  For  many  years,  Hispanic 
patients suffering from cancer faced numerous dif-
ficulties  when  trying  to  receive  medical  care. The 
barriers identified in each trial were similar to one 
another. For example, each project identified cultural, 
educational and language impediments to screening 
and treatment. These issues were addressed through 
outreach  and  education  conducted  by  community 
health workers.4,8–14 In the Hispanic population, Navi-
gator programs were instituted throughout the cancer 
care continuum (ie, prevention, screening, and treat-
ment) and proved to be significantly helpful.1–4,8–10,12 
One interesting aspect of the studies was that some 
programs employed lay community members trained 
as patient navigators, while other programs employed 
nurses or social services staff.1,2,4,9,10,12,13,16 The out-
come data, however, revealed that regardless of the 
level of education of the patient navigator, the rates 
of screening, treatment and follow up increased when 
patient navigators were employed.1,2,4,9,10,12,13,16
One of the major obstacles to obtain medical treat-
ment identified during the patient interviews was the 
communication between the patient and the health 
care  provider  and  their  staff.4,8–14  The  studies  also 
identified that when the communication between the 
healthcare provided and the patient was not available, 
problems  of  cultural  barriers  arose:  for  example 
patients felt confused, did not understand the   treatment 
and they felt disrespected or mistreated.5 The use of 
bilingual  Patient  Navigators  solved  that  problem, 
since the patient received contestant and timely tele-
phone contact.1,2,4,9,10,12,13,16 The Patient Navigator also 
provided support, assistance with scheduling, remind-
ers and also provided patients with any other support 
needed as they moved through the rigorous treatment 
involved with brain tumors.
Overall  these  studies  also  showed  that  patient 
  navigation  was  directly  associated  with  higher 
patient  satisfaction.  Both  physicians  and  patients 
believed  that  navigation  was  beneficial  for  patient 
care.1–4,10,12,13,16,20  Most  likely,  simply  by  improv-
ing  communication  between  the  providers  and  the 
patients, and thus removing the barriers that previ-
ously limited access to healthcare of these patients, 
the patients were better able to comply with screening 
rates, follow-up and to complete the treatment.
Since its inception in the 1990s, patient navigation 
was found to be a useful tool in removing barriers 
limiting the access to healthcare of minority patients. 
It was also proved to be associated with higher screen-
ing rates, improved follow-up, lower clinical stage of Robie et al
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presentation, and higher patient satisfaction overall. 
However, despite these proven benefits, patient navi-
gation  is  still  in  its  early  stages  of  development. 
  Interest and need for such programs has expanded 
and continued to gain support, making the develop-
ment of more trials and programs likely. Very recently, 
the  Patient  Navigation  Research  Program  (PNRP) 
sponsored by the National Cancer Institute’s (NCI) 
Center to Reduce Cancer Health Disparities (CRHCD) 
started to examine the role and benefits of patient 
navigation.21 The NCI PNRP is unique in examining 
the outcomes of care in patient navigation for persons 
across four different types of cancer, and across mul-
tiple diverse clinical care sites and populations. The 
goal of the NCI PNRP is to determine if patient navi-
gation can facilitate timely and quality care from the 
time  of  the  initial  cancer  screening  abnormality 
detected through the completion of the initial cancer 
therapy. It is believed that patient navigation will help 
guide the patients through the complex system, and at 
the same time, will ensure that patients will not be 
lost to follow up and treatment will be completed on 
schedule.
Health disparities among different minority popu-
lations existed for years, and for years efforts were 
made to find solutions to solve those problems associ-
ated with delivery of healthcare to the underserved. 
Judging from the data set forth in the recent years, it 
can be inferred that patient navigation can be an effec-
tive way of removing the barriers to healthcare that 
currently  still  stand  between  many  Hispanics  and 
quality medical care. By fostering teamwork among 
the patient, the provider, and the ancillary staff the 
patient  navigation  system  leads  to  improved  out-
comes. A cost benefit analysis of this system is war-
ranted, to ensure that the cost associated with patient 
navigation can be outweighed by earlier identifica-
tion of cancer and thus less costly treatment for the 
patient and the healthcare system overall.
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